ZA89986B - 3-alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds - Google Patents

3-alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds

Info

Publication number
ZA89986B
ZA89986B ZA89986A ZA89986A ZA89986B ZA 89986 B ZA89986 B ZA 89986B ZA 89986 A ZA89986 A ZA 89986A ZA 89986 A ZA89986 A ZA 89986A ZA 89986 B ZA89986 B ZA 89986B
Authority
ZA
South Africa
Prior art keywords
azabicyclo
hept
ene
alkenyl
carboxylic acid
Prior art date
Application number
ZA89986A
Other languages
English (en)
Inventor
Masayoshi Murata
Murata Masayoshi
Toshiyuki Chiba
Chiba Toshiyuki
Akira Yamada
Yamada Akira
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of ZA89986B publication Critical patent/ZA89986B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/14Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA89986A 1988-02-22 1989-02-08 3-alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds ZA89986B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888804058A GB8804058D0 (en) 1988-02-22 1988-02-22 3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds

Publications (1)

Publication Number Publication Date
ZA89986B true ZA89986B (en) 1989-10-25

Family

ID=10632122

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA89986A ZA89986B (en) 1988-02-22 1989-02-08 3-alkenyl-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid compounds

Country Status (18)

Country Link
US (2) US4923857A (pt)
EP (1) EP0330108B1 (pt)
JP (1) JP2748500B2 (pt)
KR (1) KR890013020A (pt)
CN (1) CN1037149A (pt)
AT (1) ATE132150T1 (pt)
AU (1) AU2983889A (pt)
DE (1) DE68925223T2 (pt)
DK (1) DK66789A (pt)
FI (1) FI890689A (pt)
GB (1) GB8804058D0 (pt)
HU (1) HUT49612A (pt)
IE (1) IE890500L (pt)
IL (1) IL89354A0 (pt)
NO (1) NO890723L (pt)
OA (1) OA09039A (pt)
PT (1) PT89769B (pt)
ZA (1) ZA89986B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2937911A1 (de) * 1978-09-19 1980-03-27 Daikin Ind Ltd Fluor enthaltende phenylbenzoatverbindungen, verfahren zu ihrer herstellung und ihre verwendung
US5102877A (en) * 1989-04-28 1992-04-07 Fujisawa Pharmaceutical Co., Ltd. 1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid compounds
US5258509A (en) * 1989-11-21 1993-11-02 Banyu Pharmaceutical Co., Ltd. Process for producing 2-carbon-substituted carbapenem derivatives
CA2030342A1 (en) * 1989-11-21 1991-05-22 Susumu Nakagawa Process for producing 2-carbon-substituted carbapenem derivatives
EP0465126A3 (en) * 1990-06-29 1992-03-11 Merck & Co. Inc. Carbapenem antibacterial agents
JPH06503803A (ja) * 1990-07-27 1994-04-28 藤沢薬品工業株式会社 1―アザビシクロ[3.2.0]ヘプト―2―エン―2―カルボン酸化合物
US5371215A (en) * 1991-03-20 1994-12-06 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
US5189158A (en) * 1991-03-20 1993-02-23 American Cyanamid Company 4-substituted azetidinones as precursors to 2-substituted-3-carboxy carbapenem antibiotics and a method of producing them
US6005138A (en) * 1991-09-23 1999-12-21 Florida State University Tricyclic taxanes having a butenyl substituted side-chain and pharmaceutical compositions containing them
AU745980B2 (en) * 1998-04-16 2002-04-11 Merck & Co., Inc. Titanium catalyzed preparation of carbapenem intermediates
US6395894B2 (en) 1998-04-16 2002-05-28 Philip J. Pye Process for the synthesis of carbapenem intermidiates, and compounds produced
WO1999065921A1 (en) 1998-06-17 1999-12-23 Merck & Co., Inc. Process for the synthesis of carbapenem intermediates, and compounds produced
US6194568B1 (en) 1998-07-13 2001-02-27 Merck & Co., Inc. Process for synthesizing carbapenem intermediates
KR100351660B1 (ko) * 2000-07-14 2002-09-05 한국화학연구원 2-아릴에테닐 카바페넴 유도체 및 그의 제조방법
JP4441734B2 (ja) * 2002-11-05 2010-03-31 リードケミカル株式会社 紫外線防御化合物
NZ566180A (en) 2005-07-29 2011-04-29 Resverlogix Corp Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
PL2118074T3 (pl) 2007-02-01 2014-06-30 Resverlogix Corp Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
ES2532402T3 (es) 2008-06-26 2015-03-26 Resverlogix Corporation Métodos de preparación de derivados de quinazolinona
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
EP2408454A2 (en) 2009-03-18 2012-01-25 Resverlogix Corp. Novel anti-inflammatory agents
JP5813626B2 (ja) 2009-04-22 2015-11-17 レスバーロジックス コーポレイション 新規抗炎症剤
JP6151257B2 (ja) 2011-09-09 2017-06-21 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 肺内感染症の治療方法
KR102011641B1 (ko) 2011-11-01 2019-08-19 리스버로직스 코퍼레이션 치환된 퀴나졸리논을 위한 경구 즉시 방출 제형
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
MX2015007921A (es) 2012-12-21 2016-03-03 Zenith Epigenetics Corp Compuestos heterociclicos novedosos como inhibidores de bromodominio.
US20140274993A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane-tazobactam pharmaceutical compositions
EP3100732A1 (en) 2013-03-15 2016-12-07 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
JO3789B1 (ar) 2015-03-13 2021-01-31 Resverlogix Corp التراكيب والوسائل العلاجية المعتمدة لمعالجة الامراض المتعلقة بالمتممة

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4543257A (en) * 1977-10-19 1985-09-24 Merck & Co., Inc. 1-Carba-2-penem-3-carboxylic acid
US4348320A (en) * 1976-11-19 1982-09-07 Merck & Co., Inc. Substituted azetidiones
US4465632A (en) * 1978-10-24 1984-08-14 Merck & Co., Inc. Process for preparing 1-6-and 2-substituted-1-carba-2-penem-3-carboxylic acids
US4260627A (en) * 1978-10-24 1981-04-07 Merck & Co., Inc. 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids
IE51861B1 (en) * 1978-10-24 1987-04-15 Merck & Co Inc 6-,1-and 2-substituted-1-carbapen-2-em-3-carboxylic acids,processes for the preparation of such compounds and pharmaceutical compositions comprising such compounds
US4267188A (en) * 1979-08-09 1981-05-12 Merck & Co., Inc. 5-Substituted-1-carba-pen-2-em-3-carboxylic acid
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
US4729993A (en) * 1984-12-13 1988-03-08 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkyl substituent
CA1282415C (en) * 1985-08-31 1991-04-02 Yasuhiro Kuramoto Azetidin-2-on derivatives and process for production thereof

Also Published As

Publication number Publication date
US5081237A (en) 1992-01-14
FI890689A0 (fi) 1989-02-14
PT89769B (pt) 1994-03-31
GB8804058D0 (en) 1988-03-23
US4923857A (en) 1990-05-08
DE68925223D1 (de) 1996-02-08
ATE132150T1 (de) 1996-01-15
OA09039A (fr) 1991-03-31
DK66789D0 (da) 1989-02-13
DE68925223T2 (de) 1996-06-13
IL89354A0 (en) 1989-09-10
EP0330108B1 (en) 1995-12-27
FI890689A (fi) 1989-08-23
HUT49612A (en) 1989-10-30
JPH021490A (ja) 1990-01-05
JP2748500B2 (ja) 1998-05-06
PT89769A (pt) 1989-10-04
NO890723D0 (no) 1989-02-21
KR890013020A (ko) 1989-09-20
NO890723L (no) 1989-08-23
AU2983889A (en) 1989-08-24
DK66789A (da) 1989-08-23
EP0330108A1 (en) 1989-08-30
IE890500L (en) 1989-08-22
CN1037149A (zh) 1989-11-15

Similar Documents

Publication Publication Date Title
GB8804058D0 (en) 3-alkenyl-1-azabicyclo(3 2 0)hept-2-ene-2-carboxylic acid compounds
DE68917023D1 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]-hept-2-en-2-carbonsäureverbindungen.
ATE107306T1 (de) 3-pyrrolidinylthio-1-azabicyclo (3.2.0)hept-2-en- 2-carbonsäure-verbindungen.
HU912397D0 (en) Process for producing pyrazolo-pyridine derivatives
EP0193904A3 (en) Amino acid derivatives and processes for preparation thereof
NO174886C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyrrolidin-derivater
GB8721016D0 (en) Cephem compounds